Association between vision and hearing impairment and successful aging over five years.

Abstract:

OBJECTIVE:We aimed to prospectively examine the relationship between vision and hearing loss and successful aging in a cohort of older adults. STUDY DESIGN:We analyzed 5-year data (1997-9 to 2002-4) from 1,085 adults aged 55+ years, who were free of cancer, coronary artery disease and stroke at baseline and who had complete data on sensory loss. MAIN OUTCOME MEASURES:Visual impairment was defined as visual acuity <20/40 (better eye), and hearing impairment as average pure-tone air conduction threshold >25 dBHL (500-4000 Hz, better ear). Successful aging was defined as the absence of: disability, depressive symptoms, cognitive impairment, respiratory symptoms and chronic diseases (cancer, coronary artery disease and stroke) at 5-year follow-up. RESULTS:At 5-year follow-up, 243 (22.4%) participants had died and 248 (22.9%) had aged successfully. After multivariable adjustment, participants who had either best-corrected visual impairment or bilateral hearing impairment, versus those who did not have sensory impairment at baseline, had 37% reduced odds of successful aging after 5 years: OR 0.63 (95% CI 0.43-0.94). Concurrent vision and hearing loss at baseline was not associated with 5-year aging status. Participants with moderate and severe hearing handicap at baseline had 50% and 61% reduced odds of aging successfully after 5 years, respectively. CONCLUSION:The presence of a single sensory impairment in older adults was associated with reduced odds of being disease-free and fully functional or having aged successfully, 5 years later. Objectively measured hearing loss and self-perceived hearing handicap, rather than vision loss, was more likely to negatively influence 5-year aging status.

journal_name

Maturitas

journal_title

Maturitas

authors

Gopinath B,Liew G,Burlutsky G,McMahon CM,Mitchell P

doi

10.1016/j.maturitas.2020.10.015

subject

Has Abstract

pub_date

2021-01-01 00:00:00

pages

203-208

eissn

0378-5122

issn

1873-4111

pii

S0378-5122(20)30415-1

journal_volume

143

pub_type

杂志文章
  • Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders.

    abstract::Insomnia, vasomotor symptoms (VMS) and depression often co-occur after the menopause, with consequent health problems and reductions in quality of life. The aim of this position statement is to provide evidence-based advice on the management of postmenopausal sleep disorders derived from a systematic review of the lit...

    journal_title:Maturitas

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.maturitas.2019.08.006

    authors: Silvestri R,Aricò I,Bonanni E,Bonsignore M,Caretto M,Caruso D,Di Perri MC,Galletta S,Lecca RM,Lombardi C,Maestri M,Miccoli M,Palagini L,Provini F,Puligheddu M,Savarese M,Spaggiari MC,Simoncini T

    更新日期:2019-11-01 00:00:00

  • A case-control study of endometrial cancer within a cohort.

    abstract::In a population-based prospective study it was shown that weight, height, overweight, total body size, age at first birth, parity and age at menopause are risk factors for the development of endometrial cancer. The finding that the patients had had a higher oestrogen excretion level than the controls some time before ...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/0378-5122(85)90036-2

    authors: Baanders-van Halewijn EA,Poortman J

    更新日期:1985-05-01 00:00:00

  • A clinical prescription for heart health in midlife women.

    abstract::Cardiovascular disease is the leading cause of death in women throughout the United States and Europe. Despite efforts to raise awareness, the sex-specific risk factors are still poorly recognized in both regions, and many women do not identify cardiovascular disease as a primary threat. During midlife, the incidence ...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2018.11.004

    authors: Shufelt C,Dutra E,Torbati T,Ramineni T

    更新日期:2019-01-01 00:00:00

  • Effect of dose on the absorption of estradiol from a transdermal gel.

    abstract:OBJECTIVES:To study whether dose adjustments in transdermal estradiol gel treatment would result in proportional changes in estradiol bioavailability and concentrations. METHODS:In an open study, 23 healthy postmenopausal women were treated consecutively with 0.5, 1.0 and 1.5 mg estradiol daily as a transdermal gel. E...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/s0378-5122(00)00101-8

    authors: Järvinen A,Granander M,Laine T,Viitanen A

    更新日期:2000-04-28 00:00:00

  • Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels.

    abstract::This study investigated the effect of ageing and reduction in ovarian function on whole blood serotonin levels and the effect of the oestrogen replacement in postmenopausal women on blood serotonin levels. Amenorrheic, natural postmenopausal and ovariectomised women had lower blood serotonin levels than regularly mens...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/0378-5122(93)90120-7

    authors: Gonzales GF,Carrillo C

    更新日期:1993-07-01 00:00:00

  • Anthropological perspectives of the menopause and middle age.

    abstract::A review of how the anthropologist has studied the menopause, the climacteric and middle age is given. The types of field methodology used by the anthropologist in the above-mentioned studies are described, and their application for research in other fields is suggested. Research problems which have yet to be addresse...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/0378-5122(82)90047-0

    authors: Flint M

    更新日期:1982-11-01 00:00:00

  • The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.

    abstract:OBJECTIVE:The present study was undertaken to assess the impact, effectiveness and safety of a monophasic hormone replacement treatment (HRT) for continuous use with regards to the clinical effects, bleeding patterns and lipid profile of menopausal women in four Latin American countries. DESIGN:Three hundred and six p...

    journal_title:Maturitas

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.maturitas.2004.05.014

    authors: Bassol S,Carranza-Lira S,Celis-Gonzalez C,Santoyo S,Murillo A,Martinez N,Santos J,Llaca V,de la Loza FR,Zarain J,da Fonseca AM,Camargos AF,Baracat EC,da Sá MF,Bayo J,Adaro L,Gurucharri C,Murga M,Siseles N,Sayegh F,

    更新日期:2005-03-14 00:00:00

  • Sexuality in the climacteric years.

    abstract::Menopause is a time of anatomic, physiological and psychological changes that often influence in the sexuality of aging female. Being sexual functioning an important aspect of health and well-being, doctors should have an holistic approach reassuring about the possibility of treating the various symptoms. The central ...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/s0378-5122(02)00150-0

    authors: Palacios S,Tobar AC,Menendez C

    更新日期:2002-08-30 00:00:00

  • Metabolic effect of two hormonal preparations in postmenopausal women.

    abstract:OBJECTIVES:To compare the metabolic and endocrinological effects of estradiol valerate/cyproterone acetate (EV/CPA) to a regimen of conjugated estrogens/medroxyprogesterone acetate (CE/MPA) in postmenopausal women. METHODS:Lipid profile, endocrinological parameters, coagulation factors, renin and angiotensinogen were ...

    journal_title:Maturitas

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0378-5122(97)00042-x

    authors: Bissonnette F,Lussier-Cacan S,Fugère P,Bérubé S

    更新日期:1997-07-01 00:00:00

  • Perimenopausal patterns of gonadotrophins, immunoreactive inhibin, oestradiol and progesterone.

    abstract::In order to assess the possible role of circulating immunoreactive inhibin (INH) during the menopausal transition, two groups of subjects were studied. Four were normal volunteers, three of whom had developed their first symptoms of cycle irregularity at age 45-46 years, the fourth being aged 37, a volunteer for a stu...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/0378-5122(93)90026-e

    authors: Hee J,MacNaughton J,Bangah M,Burger HG

    更新日期:1993-12-01 00:00:00

  • The mechanisms tumor cells utilize to evade the host's immune system.

    abstract::The immune system plays an essential role in the tumor progression; not only can it inhibit tumor growth but it can also promote tumor growth by establishing a favorable environment. Tumor cells utilize several strategies to evade the host's immune system, including expression of immunosuppressive molecules such as PD...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2017.04.014

    authors: Kuol N,Stojanovska L,Nurgali K,Apostolopoulos V

    更新日期:2017-11-01 00:00:00

  • The risk factors and symptomatology of perimenopausal depression.

    abstract:OBJECTIVES:The aim of this study is to determine if the depression in perimenopausal women is symptomatologically different than depression in premenopausal women, and if these depressive women are under more risk for depression when factors like premenstrual dysphoric syndrome, socio-economical status, vasomotor sympt...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2006.02.001

    authors: Oztürk O,Eraslan D,Mete HE,Ozşener S

    更新日期:2006-09-20 00:00:00

  • Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight.

    abstract::The effect of two forms of exogenous estrogen and a placebo on diastolic blood pressure and bodyweight was evaluated in 50 oophorectomized women. There was no significant change in bodyweight on any form of treatment, nor was there any significant elevation in mean diastolic blood pressure. However, 2 out of 49 female...

    journal_title:Maturitas

    pub_type: 临床试验,杂志文章

    doi:10.1016/0378-5122(78)90003-8

    authors: Utian WH

    更新日期:1978-06-01 00:00:00

  • Clinical characteristics and the risk for malignancy in postmenopausal women with adnexal torsion.

    abstract:OBJECTIVE:To compare clinical characteristics and management of adnexal torsion in postmenopausal patients as compared to premenopausal ones. METHODS:A retrospective 22 year cohort of all cases of surgically verified adnexal torsion in postmenopausal and premenopausal patients, comparing presentation, imaging, surgica...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2015.02.261

    authors: Ganer Herman H,Shalev A,Ginath S,Kerner R,Keidar R,Bar J,Sagiv R

    更新日期:2015-05-01 00:00:00

  • Clinical audit of estradiol implant therapy: Long duration of action and implications in non-hysterectomised women.

    abstract::We audited the files of 114 postmenopausal women who had been treated with subcutaneous Estrapel (50mg oestradiol implants). Of the 92 women who received more than one implant, the median number of days between implants was 223.5 (range 49-875), with an estimated median time to return to baseline of 311days (range 108...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2016.09.008

    authors: Wheatley S,Bell RJ,Stuckey BG,Robinson PJ,Davis SR

    更新日期:2016-12-01 00:00:00

  • Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.

    abstract:OBJECTIVE:The objective of this study was to determine the relationships of serum estrogen levels after hormone replacement therapy (HRT) every other day and every day with body mass index (BMI) in postmenopausal and bilaterally ovariectomized women. METHODS:Eighty-six postmenopausal and 51 bilaterally ovariectomized ...

    journal_title:Maturitas

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.maturitas.2004.03.013

    authors: Yasui T,Uemura H,Umino Y,Takikawa M,Saito S,Kuwahara A,Matsuzaki T,Maegawa M,Furumoto H,Miura M,Irahara M

    更新日期:2005-01-10 00:00:00

  • Estradiol valerate therapy and the renin--aldosterone system in castrated women.

    abstract::The effect of estradiol valerate (Progynova, 2 mg daily) on the renin--aldosterone system was studied in nine women after bilateral oophorectomy. Plasma renin activity (PRA) and the daily urinary excretion of aldosterone (dU-Ald) were determined 4 mth after the operation -- during which no estrogen was given -- and af...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/0378-5122(80)90041-9

    authors: Punnonen R,Lammintausta R,Erkkola R,Rauramo L

    更新日期:1980-07-01 00:00:00

  • Age at menopause onset and risk of cardiovascular disease around the world.

    abstract::Earlier menopause onset has been linked to a greater risk of cardiovascular disease. Both menopause onset and cardiovascular disease risk vary by geographical region, race/ethnicity and socioeconomic status. As such, it is plausible to hypothesize that these factors may influence the association of menopause onset and...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2020.06.007

    authors: El Khoudary SR

    更新日期:2020-11-01 00:00:00

  • Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program.

    abstract:BACKGROUND:Quality of life decreases after the menopause as it has been assessed by several designed tools. Despite this, few studies have reported correlations between quality of life and the metabolic syndrome and its determinants. OBJECTIVE:Evaluate quality of life and determine factors related to its impairment am...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2006.05.008

    authors: Chedraui P,Hidalgo L,Chavez D,Morocho N,Alvarado M,Huc A

    更新日期:2007-01-20 00:00:00

  • Vitamin D and cardiovascular disease.

    abstract::Vitamin D, a soluble steroid hormone synthesized in the skin after sun exposure, plays a crucial role in calcium metabolism and is also involved in cardiovascular pathophysiology. The aim of this review is to summarize the available evidence (a) on the association between endogenous vitamin D status and cardiovascular...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2018.05.010

    authors: Apostolakis M,Armeni E,Bakas P,Lambrinoudaki I

    更新日期:2018-09-01 00:00:00

  • EMAS position statement: Bone densitometry screening for osteoporosis.

    abstract:INTRODUCTION:Osteoporosis and its consequent fractures is a major public health problem. AIM:To formulate a position statement on the use of bone densitometry in screening postmenopausal women for osteoporosis and in their management. MATERIALS AND METHODS:Literature review and consensus of expert opinion. RESULTS A...

    journal_title:Maturitas

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.maturitas.2010.09.009

    authors: Brincat M,Calleja-Agius J,Erel CT,Gambacciani M,Lambrinoudaki I,Moen MH,Schenck-Gustafsson K,Tremollieres F,Vujovic S,Rees M,Rozenberg S,EMAS.

    更新日期:2011-01-01 00:00:00

  • A model of care for healthy menopause and ageing: EMAS position statement.

    abstract::Worldwide, the number of menopausal women is increasing. They present with complex medical issues that lie beyond the traditional scope of gynaecologists and general practitioners (GPs). The European Menopause and Andropause Society (EMAS) therefore provides a holistic model of care for healthy menopause (HM). The HM ...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2016.06.018

    authors: Stute P,Ceausu I,Depypere H,Lambrinoudaki I,Mueck A,Pérez-López FR,van der Schouw YT,Senturk LM,Simoncini T,Stevenson JC,Rees M

    更新日期:2016-10-01 00:00:00

  • The effect of occupation type on risk of Alzheimer's disease in men and women.

    abstract:OBJECTIVES:To examine the association between the principal lifetime occupation and the incidence of Alzheimer's disease (AD) in men and women in a southern European population aged 55 years or more. STUDY DESIGN:A community-dwelling sample of 3883 dementia-free individuals aged 55 years or over was classified accordi...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2019.05.008

    authors: Santabárbara J,Gracía-Rebled AC,López-Antón R,Tomás C,Lobo E,Marcos G,Lobo A

    更新日期:2019-08-01 00:00:00

  • Evaluating the content and development of decision aid tools for the management of menopause: A scoping review.

    abstract:OBJECTIVE:Decision-making during menopause (especially surgical menopause) can be complex given the variability in risk-benefit perceptions of menopausal treatments. Decision aid tools (DATs) help women participate in decision-making about options. Our objective is to identify and evaluate the content and development o...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2017.09.006

    authors: Siyam T,Sultani H,Ross S,Chatterley T,Yuksel N

    更新日期:2017-12-01 00:00:00

  • Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.

    abstract:OBJECTIVES:Association studies between estrogen receptor alpha (ERalpha) gene polymorphisms and bone mineral density (BMD) have yielded inconsistent results. In the present study we evaluated the influence of XbaI and PvuII ERalpha gene polymorphisms on BMD, biochemical markers, rates of bone loss and the response to e...

    journal_title:Maturitas

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.maturitas.2005.07.007

    authors: Rapuri PB,Gallagher JC,Knezetic JA,Haynatzka V

    更新日期:2006-03-20 00:00:00

  • Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.

    abstract:OBJECTIVE:Alterations in sleep quality and metabolism during menopause are improved by menopausal hormone therapy (MHT). The mechanisms mediating these effects remain unclear. Orexin A (OxA) is a neuro-peptide that regulates sleep/wakefulness, food intake and metabolism. This study examined changes in plasma OxA levels...

    journal_title:Maturitas

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.maturitas.2017.01.016

    authors: Cintron D,Beckman JP,Bailey KR,Lahr BD,Jayachandran M,Miller VM

    更新日期:2017-05-01 00:00:00

  • Lessons to be learned from clinical studies on hormones and the breast.

    abstract::Estrogen is a well-known mitogen in human breast epithelium but the action of progestogen is complex and incompletely understood. During the last years, accumulating data from animal, clinical and observational studies suggest a proliferative effect in breast tissue when progestogen is added to estrogen. Findings in s...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2004.06.008

    authors: Söderqvist G,von Schoultz B

    更新日期:2004-09-24 00:00:00

  • Efficacy and tolerability of calcium, vitamin D and a plant-based omega-3 oil for osteopenia: a pilot RCT.

    abstract:OBJECTIVES:Our pilot study tested the efficacy, acceptability and tolerability of DHA supplementation in addition to calcium and vitamin D in individuals with osteopenia. STUDY DESIGN:40 participants were randomised to either algal oil containing 400mg docosahexanoic acid (DHA) daily or placebo. All participants recei...

    journal_title:Maturitas

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.maturitas.2011.10.004

    authors: Vanlint SJ,Ried K

    更新日期:2012-01-01 00:00:00

  • Cognitive behavior therapy for menopausal hot flashes: two case reports.

    abstract::Two case reports of women treated with an individual cognitive behavioral treatment (CBT) for menopausal hot flashes are presented. Both women reported substantial improvements in the number of hot flashes experienced as well as in their quality of life as measured by the Menopause Quality of Life Scale (MENQOL), the ...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2005.12.006

    authors: Allen LA,Dobkin RD,Boohar EM,Woolfolk RL

    更新日期:2006-04-20 00:00:00

  • Bone mineral density in breast cancer patients with positive estrogen receptor tumor status.

    abstract:AIM:The aim was to investigate bone mineral density (BMD) in breast cancer patients with positive estrogen receptor (ER) tumor status. METHODS:The participants were 110 postmenopausal breast cancer patients with positive estrogen receptor (ER+) tumor status. Two hundred and sixty-one age-matched, healthy postmenopausa...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2006.11.012

    authors: Douchi T,Yonehara Y,Kosha S,Iwamoto I,Rai Y,Sagara Y,Umekita Y

    更新日期:2007-07-20 00:00:00